Methotrexate: Long-term safety and efficacy in an Australian consultant rheumatology practice

Internal Medicine Journal

Volumn 39, Issue 4, 2009, Pages 228-236

  Varatharajan, N ^a   Lim, I G S ^b   Anandacoomarasamy, A ^b   Russo, R ^b   Byth, K ^c   Spencer, D G ^b   Manolios, N ^b   Howe, G B ^a,b,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Rheumatology ^*  (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d Arcade 83   (Australia)

Author keywords

Adverse reaction; Methotrexate; Monitoring guideline; Rheumatoid arthritis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; GOLD; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; MINOCYCLINE; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; AMNESIA; ARTHRALGIA; ARTICLE; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; COUGHING; DIARRHEA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; HAIR LOSS; HEADACHE; HOT FLUSH; HUMAN; IRRITABILITY; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MASTALGIA; MEDICAL PRACTICE; MYOPATHY; NAUSEA; NEUTROPENIA; PANCREATITIS; PNEUMONIA; PRIORITY JOURNAL; PRURITUS; RASH; RECURRENT INFECTION; REMISSION; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS; TEACHING HOSPITAL; THORAX PAIN; THROMBOCYTOPENIA; TREATMENT DURATION; VASCULITIS; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BIOPSY; FEMALE; GASTROINTESTINAL DISEASES; HEPATITIS, TOXIC; HOSPITALS, TEACHING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; LIVER; MALE; METHOTREXATE; MIDDLE AGED; NEW SOUTH WALES; PRACTICE GUIDELINES AS TOPIC; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RHEUMATOLOGY; YOUNG ADULT;

EID: 65349158219     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.01800.x     Document Type: Article

References (21)

1. Gubner RAS, Ginsburg V. Therapeutic suppression of tissue reactivity. Effects of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci 1951 221 : 176 82.
2. Williams HJ, Wilkens RF, Samuelson CO Jr., Alarcon GS, Guttadauria M, Yarboro C et al. Comparison of low-dose oral pulse MTX and placebo in the treatment of rheumatoid arthritis. Arthritis Rheum 1985 28 : 721 30.
3. Thompson RN, Watts C, Edelman J, Esdaile J, Russell AS. A controlled two-centre trial of parenteral MTX therapy for refractory rheumatoid arthritis. J Rheumatol 1984 11 : 760 63.
4. Andersen PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL. Weekly pulse MTX in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med 1985 103 : 489 96.
5. Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN et al. Efficacy of low-dose MTX in rheumatoid arthritis. N Engl J Med 1985 312 : 818 22.
6. Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis: a metaanalysis of published clinical trials. Arthritis Rheum 1992 35 : 1117 25.
7. Maetzel A, Wong A, Strand V, Tugwell P, Wells G, Bombardier C. Metaanalysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology 2000 39 : 975 81.
8. Mikulus TR, O'Dell J. The changing face of rheumatoid arthritis: results of serial surveys. Arthritis Rheum 2000 43 : 464 7.
9. Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N et al. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with MTX. Utilization of leflunomide in the treatment of Rheumatoid Arthritis Trial Investigator Group. Arthritis Rheum 2001 44 : 1984 92.
10. Hamilton J, McInnes IB, Thomson EA, Porter D, Hunter JA, Madhok R et al. Comparative study of intramuscular gold and MTX in a rheumatoid arthritis population from a socially deprived area. Ann Rheumatic Dis 2001 60 : 566 72.
11. Hoekstra M, van Ede AE, Haagsma CJ, van de Laar MA, Huizinga TW, Kruijsen MW et al. Factors associated with toxicity, final dose, and efficacy of MTX in patients with rheumatoid arthritis. Ann Rheumatic Dis 2003 62 : 423 6.
12. van Ede AE, Laan RF, Rood MJ, Huizinga TW, van de Laar MA, van Denderen CJ et al. Effect of folic or folinic acid supplementation on the toxicity and efficacy of MTX in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2001 44 : 1515 24.
13. van Jaarsveld CH, Jahangier ZN, Jacobs JW, Blaauw AA, van Albada-Kuipers GA, ter Borg EJ et al. Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis. Rheumatology 2000 39 : 1374 82.
14. Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP, Dawes PT, Gomor B et al. A comparison of the efficacy and safety of leflunomide and MTX for the treatment of rheumatoid arthritis. Rheumatology 2000 39 : 655 65.
15. Kremer JM, Alarcon GS, Lightfoot RW Jr., Wilkens RF, Furst DE, Williams HJ et al. MTX for rheumatoid arthritis: suggested guidelines for monitoring liver toxicity. Arthritis Rheum 1994 37 : 316 28.
16. Endresen GKM, Husby G. Folate supplementation during MTX treatment of patients with rheumatoid arthritis. An update and proposal for guidelines. Scan J Rheumatology 2001 30 : 129 34.
17. Yazici Y, Erkan D, Paget SA. Monitoring MTX hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines? J Rheumatol 2002 29 : 1586 9.
18. Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P. The efficacy of folic acid and folinic acid in reducing MTX gastrointestinal toxicity in rheumatoid arthritis: a metaanalysis of randomized controlled trials. J Rheumatol 1998 25 : 36 43.
19. Shergy WJ, Polisson RP, Caldwell DS, Rice JR, Allen NB. MTX-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis. Am J Med 1988 85 : 771 4.
20. Yazici Y, Erkan D, Paget SA. Monitoring by rheumatologists for MTX-, etanercept-, infliximab-, and anakinra-associated adverse events. Arthritis Rheum 2003 48 : 2769 72.
21. van Tuyl LHD, Lems WF, Voskuyl AE, Kerstens PJSM, Garnero P, Dijkmans BAC et al. Tight control and intensified COBRA combination therapy in early rheumatoid arthritis: 90% remission in a pilot study (Epub 2008 Jul 14). Ann Rheum Dis doi:10.1136/ard.2008.090712